- Trump awarded nearly $122,000 in attorney fees from Stormy Daniels
By WND News Services
(FOX NEWS) — Former President Donald Trump on Tuesday was awarded nearly $122,000 in attorney fees from Stormy Daniels, the porn ...
- Trump Pleads Not Guilty to 34-Count Indictment
By Ivan Pentchoukov
NEW YORK—Donald Trump, former president and frontrunner for the Republican presidential nomination in 2024, pleaded not guilty in New York on April ...
- Trump Attorney Announces Plans to File Motions to Dismiss, Alleging Prosecutorial Misconduct
By Gary Bai
Joseph Tacopina, a lawyer defending former president Donald Trump in Manhattan District Attorney Alvin Bragg’s hush money case, announced late Monday his ...
- Judge Presiding Over Trump’s Arraignment Bars Video Cameras From Courtroom
By Mimi Nguyen Ly
Former President Donald Trump’s arraignment won’t be televised after a judge presiding over the case declined a request from media outlets ...
- Trump Accuses Manhattan DA of Illegally Leaking Indictment Ahead of Arraignment
By Mimi Nguyen Ly
President Donald Trump late Tuesday accused Manhattan District Attorney Alvin Bragg of having illegally leaked the contents of the indictment ahead of ...
- A ‘New Phase’ Never Seen Before: Victor Davis Hanson on What Trump Indictment Means for America
By Terri Wu and Jan Jekielek
With last week’s indictment of former President Donald Trump, the country has entered an unsettling new era characterized by chronic dysfunction, according ...
- CEOs of Multi-Billion Dollar Organization Do Not Make Accounting Entries
By Joe Hoft
The corrupt Soros-backed and Obama-connected DA’s office in Manhattan is indicting President Trump by claiming that President Trump is somehow behind accounting ...
- The Democrat Party Reportedly Received Half Its Donations from Unemployed Americans, Many Are Elderly Voters Whose Identities May Have Been Stolen – Where’s the Money Really Coming From
By Joe Hoft
In 2020 millions were reportedly donated to BLM after George Floyd was killed. At the same time, 20+ police were killed and ...
- Census Map Shows Dramatic California Exodus
By John Seiler
Commentary
Sometimes a map tells a dramatic story. That’s the case for the following map released March 30 by the U.S. Census Bureau. It shows ...
- US Manufacturing Slumps to Lowest Level in 3 Years
By Tom Ozimek
U.S. manufacturing activity contracted in March for the fourth straight month, dropping to its lowest level in nearly three years amid a ...
- US Now a Majority Permitless Carry Country After DeSantis Signs Gun Rights Law
By Jack Phillips
Florida Gov. Ron DeSantis signed a “permitless carry” bill into law on April 3, making Florida the 26th state to do so, ...
- Rep. Jordan Says Subpoena ‘On the Table’ for Manhattan DA After Trump Indictment
By Ryan Morgan
Rep. Jim Jordan (R-Ohio) said a subpoena is on the table if it will compel Manhattan District Attorney (DA) Alvin Bragg to ...
![Recent documents disclosed as part of a Freedom of Information Act (FOIA) lawsuit against the U.S. Food and Drug Administration (FDA) show the agency knew its safety monitoring system was “not sufficient” for assessing the risk of heart conditions associated with Pfizer’s COVID-19 vaccine when it licensed the company's “Comirnaty” vaccine. Documents also reveal numerous manufacturing problems in Pfizer batches released to the public and show the FDA knew about a phenomenon known as vaccine-associated enhanced disease (VAED) in those vaccinated who experience breakthrough COVID-19. The FDA released the final batch of documents it relied upon in licensing Pfizer’s Comirnaty COVID-19 vaccine for ages 16 and up—more than 800 days after the agency approved the shot. The memo states: “The CBER Sentinel Program is NOT sufficient to assess the serious risks of myocarditis and pericarditis, and subclinical myocarditis associated with COMIRNATY (BNT162b2) in lieu of PMR safety studies under FDAAA [Food and Drug Administration Amendments Act]. “At the time of BLA [Biologics License Application] approval, the data sources in the CBER Sentinel Program are not sufficient to identify the outcomes due to lack of sufficient power to assess the magnitude of risk in patients 12-30 years of age. In addition, CBER Sentinel Program is not sufficient to follow up cases for recovery status and long-term sequelae, or for identification and characterization of subclinical myocarditis cases.” Cardiac Disorders Higher in Vaccine Trial Group According to an Aug. 23, 2021, BLA Clinical Review Memorandum, there were more cardiac disorders in trial participants who received Pfizer’s COVID-19 vaccine compared to the placebo group and more instances of tachycardia in the younger vaccinated age group. Cardiac conditions were reported as the cause of death in nine participants 25 to 128 days after having received at least one dose of Pfizer’s COVID-19 vaccine, including seven cases of cardiac arrest, one case of cardiovascular disease, and one case of congestive heart failure. Five cardiac-related deaths in the placebo group occurred 15 to 81 days after having received a placebo, including two cases of myocardial infarction, one aortic rupture, and two cardiac arrests. “Because COVID-19 mRNA and its Spike protein are found in the human heart at autopsy causing inflammation and heart damage, it is incontrovertible that the COVID-19 vaccines are cardiotoxic,” cardiologist Dr. Peter McCullough told The Epoch Times in an email. “Younger individuals with healthy hearts take up more of the damaging vaccine into the cardiac tissue resulting in symptoms of chest pain, palpitations, fluctuations in blood pressure, dizziness, and sadly, some, end up with cardiac arrest either during exercise or in the early morning waking hours. At both time periods, an internal surge of adrenalin appears to be the trigger for the fatal arrhythmia in those with COVID-19 vaccine myocarditis,” he added. Despite nearly double the number of reported cardiac events in vaccine recipients versus placebo recipients, the FDA concluded the deaths were “unlikely to be related to vaccination.” “As a cardiologist, these serious adverse events are unacceptable,” Dr. McCullough said. “I have called for all COVID-19 vaccines to be removed from the market with an urgent push for research strategies to prevent cardiac death after injection.” Vaccines Released Despite Manufacturing Issues According to the Pfizer Andover Response to Form FDA 483 included in the released documents, numerous manufacturing issues and inadequacies in quality oversight were also identified. Several batches of COVID-19 vaccines were flagged for deviating from product quality standards, yet the affected batches were released to the public in various lots, the numbers of which were redacted. In November 2021, whistleblower Brook Jackson, who worked as a regional director at testing sites by Pfizer contractor Ventavia, told the British Medical Journal that Pfizer's trial was riddled with issues. Ms. Jackson said the company “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.” Ms. Jackson, a trained clinical trial auditor with more than 15 years of experience in clinical research coordination and management, emailed a complaint to the FDA and was fired later that day. She subsequently filed a lawsuit against Ventavia and Pfizer, alleging Pfizer had defrauded the government while developing its COVID-19 vaccine. FDA Acknowledges Vaccine-Associated Enhanced Disease In its Pharmacovigilance Plan Review Memorandum, the FDA referenced a condition called “vaccine-associated enhanced disease.” According to the journal Vaccine, VAED is the modified presentation of a clinical infection affecting individuals exposed to the wild-type pathogen after having received a vaccine for the same pathogen. In its memo, the FDA stated there are reported deaths in the Vaccine Adverse Event Reporting System (VAERS) in patients reported to be fully vaccinated. Although the agency said that passive surveillance and spontaneous adverse event reporting generally cannot be used to conclude vaccine effectiveness because of the lack of a control group, reporter bias, and underreporting, “severe manifestations and death from COVID-19” increase the possibility of developing VAED, which has “overlapping clinical manifestations with natural SARS-CoV-2 infection, making it difficult to differentiate VAED from severe COVID-19 disease in individual VAERS reports.” The FDA said Pfizer was assessing the condition in its continuation of Phase 3 clinical studies and active surveillance studies. VAED has been observed in other vaccine trials involving the dengue virus, respiratory syncytial virus, and measles. FDA Took Over 800 Days to Release Data The Public Health and Medical Professionals for Transparency (PHMPT), a nonprofit consisting of public health and medical professionals, scientists, and journalists, filed a FOIA lawsuit against the FDA in September 2021 to force the release of hundreds of thousands of documents relied upon by the agency in licensing Pfizer’s COVID-19 vaccine for individuals age 16 and older. Even though the FDA said in a news release it was committed to “ensuring full transparency, dialogue and efficiency” regarding COVID-19 vaccines and reiterated its commitment to full transparency when it licensed Pfizer's Comirnaty vaccine, they wanted 75 years to produce an estimated 451,000 documents at a rate of 500 pages per month. It previously estimated it had 329,000 pages of responsive records and wanted 55 years to release them to the public. Attorney Aaron Siri, who filed the lawsuit on behalf of the group, said the federal government was shielding Pfizer from liability, gave it billions of dollars, and forced Americans to get vaccinated while preventing the safety and efficacy data supporting the licensure of Pfizer’s COVID-19 vaccine from being released until the year 2076. Yet it only took 108 days from when Pfizer started producing records to the agency for the FDA to license its vaccine.](https://www.usnn.news/wp-content/uploads/2023/12/Final-Batch-of-Pfizer-Documents-Released-Shows-FDA-Knew-Safety-Monitoring-System-Was-Not-Sufficient.jpg "Final Batch of Pfizer Documents Released Shows FDA Knew Safety Monitoring System Was 'Not Sufficient' 9")
